×

Express Scripts' move weighs US biotech plays: Pro

6:43 PM ET Tue, 23 Dec 2014

Express Scripts' decision to drop Gilead's Sovaldi treatment sparked fears that pharmaceutical firms may have to bow to pricing pressure moving forward, says Andrew McDonald, Co-Portfolio Manager at BioShares Funds.